Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 25:2026:1620175.
doi: 10.1155/crip/1620175. eCollection 2026.

Uterine PEComa With Lymphangioleiomyomatosis (LAM)-Like Features: A Case Report

Ramani Raman  1 , Daisy Maharjan  1 , Carina Dehner  2 , Sheila Segura  1
Affiliations

Uterine PEComa With Lymphangioleiomyomatosis (LAM)-Like Features: A Case Report

Ramani Raman et al. Case Rep Pathol. .

Abstract

Perivascular epithelioid cell tumors (PEComas) of the uterus are rare mesenchymal neoplasms characterized by myogenic and melanocytic differentiation. These tumors can mimic other uterine mesenchymal tumors in their clinical presentation and morphology. We report a case of a 58-year-old woman who presented with abnormal uterine bleeding. Initial imaging revealed an endometrial polyp, which was later diagnosed as a leiomyoma on excision biopsy. A subsequent hysterectomy with bilateral salpingectomy revealed a uterine neoplasm composed of spindled to epithelioid cells with low-grade cytologic atypia, infiltrative edges, and extensive lymphovascular invasions, initially suggestive of low-grade endometrial stromal sarcoma. However, immunohistochemical stains demonstrated tumor positivity for HMB45, desmin, and Cathepsin K, and genetic testing revealed a TSC1 variant, leading to a definite diagnosis of uterine PEComa with lymphangioleiomyomatosis (LAM)-like features. The patient's postoperative course was uneventful, and follow-up imaging showed no evidence of metastatic disease. This case highlights the importance of integrated morphological, immunohistochemical, and molecular assessment in differentiating uterine mesenchymal neoplasms to guide appropriate clinical management.

Keywords: PEComas; TSC1; lymphangioleiomyomatosis; uterus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

None
(a)
None
(b)
None
(c)
None
(d)
None
(e)
None
(f)
None
(g)
None
(h)
See this image and copyright information in PMC

References

    1. Pea M., Martignoni G., Zamboni G., and Bonetti F., Perivascular Epithelioid Cell, American Journal of Surgical Pathology. (1996) 20, no. 9, 1149–1153, 8764751, 10.1097/00000478-199609000-00012, 2-s2.0-0030240771. - DOI - PubMed
    1. Gadducci A. and Zannoni G. F., Perivascular Epithelioid Cell Tumors (PEComa) of the Female Genital Tract: A Challenging Question for Gynaecologic Oncologist and Pathologist, Gynecologic Oncology Reports. (2020) 33, 100603, 10.1016/j.gore.2020.100603. - DOI - PMC - PubMed
    1. Folpe A. L., Mentzel T., Lehr H. A., Fisher C., Balzer B. L., and Weiss S. W., Perivascular Epithelioid Cell Neoplasms of Soft Tissue and Gynecologic Origin: A Clinicopathologic Study of 26 Cases and Review of the Literature, American Journal of Surgical Pathology. (2005) 29, no. 12, 1558–1575, 16327428, 10.1097/01.pas.0000173232.22117.37, 2-s2.0-33644797611. - DOI - PubMed
    1. Akumalla S., Madison R., Lin D. I., Schrock A. B., Yakirevich E., Rosenzweig M., Balar A. V., Frampton G. M., Edgerly C., Erlich R. L., Miller V. A., Ganesan S., Ross J. S., and Ali S. M., Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNA, Oncology. (2020) 98, no. 12, 905–912, 10.1159/000510241, 32966992. - DOI - PubMed
    1. Izubuchi Y. and Tanaka T., PEComa-Its Clinical Features, Histopathology, and Current Therapy, Japanese Journal of Clinical Oncology. (2025) 55, no. 7, 691–698, 10.1093/jjco/hyaf056, 40336169. - DOI - PubMed

LinkOut - more resources